The Model Withdrawal Management Protocol in Correctional Settings Act requires evidence-based treatment of substance use disorders, including the use of FDA-approved medications; requires correctional settings to establish and implement administrative and clinical protocols when detaining individuals at risk of withdrawal; and provides state legislators, policymakers, and those in the correctional and health care professions with a comprehensive framework to better respond to withdrawal symptoms and related mental health crises of individuals in custody to decrease their mortality while in correctional settings. Click here to read the full Model Withdrawal Management Protocol in Correctional Settings Act.
The Model Access to Medication for Addiction Treatment in Correctional Settings Act, written in collaboration with the O’Neill Institute for National and Global Health Law at the Georgetown University Law Center and a cadre of subject matter experts, sets forth a comprehensive, evidence-based framework for ensuring that all incarcerated individuals with a substance use disorder be provided access to FDA-approved medication for addiction treatment in state and local correctional settings. Click here to read the full Model Access to Medication for Addiction Treatment in Correctional Settings Act.
Click here to learn more about MAT in correctional settings, including a map of jurisdictions that require access to medication for addiction treatment in all – or nearly all – state and local correctional facilities via either statewide law or protocol/policy.
Click here to learn more about withdrawal management in correctional settings, including a map of jurisdictions that support incarcerated individuals in need of withdrawal management by requiring state or local correctional settings to provide withdrawal management services, via either statewide law or protocol/policy.
Click here to learn more about funding to support treatment in correctional settings.